Post Approval Changes on Registered Drugs in Jordan

Last week The Jordan Food & Drug Administration (JFDA) has been awarded with The King Abdulla II Award for Excellence in Governmental Performance and Transparency- First Place.

What an Honor for this distinguished administration, that despites all the obstacles and limited resources, still keeping the highest standards for the pharmaceuticals & Nutrients in Jordan.

On the same week, we were delighted by a new cooperation with this great administration to deliver an informative workshop about the “Post Approval Changes on Registered Drugs in Jordan”.

The workshop discussed the variations happen in the drug life cycle, their different classifications, the needed requirements for both biological & chemical drugs, the proposed changes in the future and the common deficiencies.

All the appreciation & gratitude for our colleagues at The Jordan Food & Drug Administration (JFDA) under the leadership of H/E Dr. Nizar Muheidat, for the continuous cooperation & support.

Special thanks to the amazing speakers Dr. Ala Al-Awamleh, Dr. Sawsan Shahin, Dr. Suzan Hameda from the drug registration Department at the JFDA.

The workshop was attended by experienced professionals from The Jordan Food & Drug Administration team, distinguished members from DOA, and representatives from various multinational & local pharmaceutical companies and distributors, all of whom contributed to the rich discussions and insights gained during the event.

Author: Diala Shahin

Latest news

Did You Enjoy This Article?

Join our community of 3 million people and get updated every week We have a lot more just for you! Lets join us now

continue reading